FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) for KRW21.7 billion on February 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,190 KRW | +3.30% | -1.57% | -19.93% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,190 KRW | +3.30% | -1.57% | 53.36M | ||
1,370 KRW | +10.31% | +8.64% | 68.78M | ||
1st Jan change | Capi. | |
---|---|---|
-19.93% | 53.36M | |
+18.55% | 7.39B | |
-17.11% | 1.8B | |
-5.59% | 1.28B | |
-17.35% | 1.09B | |
+4.14% | 578M | |
-47.34% | 512M | |
-33.57% | 500M | |
+15.10% | 448M | |
-33.05% | 374M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion.